StockData
Opus Genetics, Inc. logo

Opus Genetics, Inc. (IRD) stock

IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.99−0.09 (-2.21%)

Close on Nov 20, 2026Market cap $331.95MP/E –Yield –

Opus Genetics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2020 it was -$6.80M.

Annual free cash flow

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$6.80M–
FY2019Dec 31, 2019-$3.62M–

More Opus Genetics figures

See a number that looks wrong?